Company Update (NASDAQ:CELG): Robbins Arroyo LLP: Acquisition of Receptos, Inc. (RCPT) by Celgene Corporation (CELG) May Not Be in Shareholders’ Best Interests

[PR Newswire] – SAN DIEGO, July 14, 2015 /PRNewswire/ — Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Receptos Inc. (RCPT) by Celgene Corporation (CELG). On July 14, . . . → Read More: Company Update (NASDAQ:CELG): Robbins Arroyo LLP: Acquisition of Receptos, Inc. (RCPT) by Celgene Corporation (CELG) May Not Be in Shareholders’ Best Interests Similar Articles: Market Update: Celgene Corporation (NASDAQ:CELG) – Celgene Corporation to Webcast at Upcoming Investor Conferences in June Company Update (NYSE:ACE): ACE Aviation reports 2014 annual results, announces intent to seek Court approval for a $115 million distribution to shareholders and provides an update on its liquidation process Company Update: Celgene Corporation (NASDAQ:CELG) – Phase II Data for Celgene’s Investigational Oral GED-0301 for Patients with Active Crohn’s Disease Published in New England Journal of Medicine